Skip to main content
Why medical cannabis is never prescribed in resin form

Why medical cannabis is never prescribed in resin form

5 min read

Sarah Sinclair

Medical Cannabis in Flower Form

Cannabis-based medicinal products (CBMPs) are now prescribed in a variety of forms in the UK. But one product type you won’t find in the formulary is cannabis resin. In this article, we explore the important reasons behind this and look at the safer alternatives available through medical cannabis clinics like Releaf. 

Key takeaways

  1. Cannabis resin is a concentrated form of cannabis which has been used in different cultures for centuries.
  2. It is never prescribed for medical use in the UK due to concerns around safety, dosing accuracy and standardisation.
  3. Resin tends to contain very high levels of THC, which may increase the risk of unwanted side-effects.
  4. Pharmaceutical-grade CBMPs come in a variety of formats and are prescribed under the guidance of a healthcare professional.

Contents

What is cannabis resin?

Cannabis resin, often recreationally formulated into hashish, is a concentrated form of cannabis. 

It is produced by collecting and compressing the trichomes. Glandular trichomes are small crystal-like structures found on cannabis flowers, which contain high concentrations of cannabinoids such as THC and CBD—as well as the various terpenes— that contribute to its potential psychoactive and therapeutic effects.

Resin is typically produced through traditional methods like hand-rubbing live plants, dry-sieving dried cannabis material, or using ice water extraction. The end product can vary in colour from light tan to dark brown or black, and in consistency from soft and pliable to hard and brittle. 

Is cannabis resin legal?

While medical cannabis is legal in the UK on prescription, cannabis for recreational use remains a Class B controlled substance under the Misuse of Drugs Act 1971. Using or possessing unregulated cannabis resin carries significant legal risks, including potential fines and imprisonment.

Why is cannabis resin not prescribed in the UK?

Although cannabis resin has been collected and consumed in different cultures for centuries, it is not prescribed by medical cannabis clinics in the UK. This is due to a number of factors which make it unsuitable for use in the manufacture of cannabis-based medicinal products (CBMPs).

Lack of standardisation 

One of the primary reasons is the lack of standardisation in its production. Unlike CBMPs, which undergo rigorous quality control processes, traditional resin production methods can result in significant variations in cannabinoid concentrations, product consistency, extraction efficiency and potential contaminants. 

Safety concerns

Beyond lack of standardisation and legal concerns, in a medical context cannabis resin may pose potential health and safety risks to patients, particularly as it tends to contain very high levels of THC. 

The unknown (and potentially very potent) levels of THC increase the risk of someone experiencing unwanted side-effects, such as anxiety and paranoia or nausea. 

Without the strict testing and manufacturing processes involved in the production of medical cannabis, there is not only an increased risk of inconsistent quality, but possible contamination with harmful substances and exposure to pesticides, heavy metals, or other toxins.

Difficulties with dosing 

Accurate dosing is crucial in medical cannabis. Medical professionals need to be able to prescribe exact doses and make careful adjustments based on the patient's response. 

However, the inconsistent nature of traditional resin makes it very challenging to achieve this level of precision and to track intake accurately. This is another factor which could potentially compromise patient safety, as well as reducing how effective the treatment is for symptom management.

Forms of medical cannabis in the UK

Medical cannabis products are different to resin which is generally produced for recreational use.

One key factor is that producers of CBMPs, such as Glass Pharms and SOMAI Pharmaceuticals, operate under strict Good Manufacturing Practice (GMP) guidelines. 

As a result, their products undergo extensive testing for potency, purity, and consistency, ensuring patients receive reliable medication every time.

UK medical cannabis clinics offer a varied formulary of pharmaceutical-grade products that provide reliable and standardised treatment options. 

Some of the options available at medical cannabis clinics in the UK include:

  • Dried flower products
  • Cannabis oils
  • Oral sprays
  • Capsules and tablets

This variety in formulation is important as cannabis is a very personalised medicine. It allows healthcare professionals to tailor treatment plans to individual patient needs and adjust this as required. 

Professional guidance 

If you’re thinking about trying medical cannabis to manage an ongoing health issue, it is crucial to do so under the guidance of a qualified clinician. As a starting point, Releaf’s free eligibility checker can help determine if the medical cannabis treatment is appropriate for you. One of the team of specialist doctors will then work with you to find the right product and dosage for your needs. 

Final thoughts 

While cannabis resin may have historical and cultural significance in many parts of the world, it is not suitable for use as a modern medical cannabis treatment. These products require a standardised, pharmaceutical-grade approach to ensure that patients receive the most effective and consistent treatment possible for their conditions, while reducing the risk of any unwanted side-effects. 

It is important to seek medical advice before starting any new treatments. The patient advisors at Releaf are available to provide expert advice and support. Alternatively, click here to book a consultation with one of our specialist doctors.

Elevate your wellness with medical cannabis

Get comprehensive care, convenience, and confidence with an all-in-one treatment plan.

Am I eligible?

Further reading

The treatment option 1.77 million Brits source illegally: UK’s legal medical cannabis access gap explained

A recent paper clearly highlights the huge gap between how many adults in the UK rely on illicit cannabis to help control the symptoms of their health conditions, compared to the numberlegally prescribed. An estimated 1.77 million UK adults still self-medicate with street-bought cannabis, with only around 100,000 having a legal UK medical cannabis prescription right now, despite medical cannabis being a fully legal treatment option since November 2018.

Pride, PTSD, and plant-based approaches

Each year in June, LGBTQ+ Pride events take place around the world. These events offer an opportunity to celebrate the LGBTQ+ community, honour their contributions, and recognise the ongoing struggle for equality. But June also marks PTSD Awareness Month and, as these two important events coincide, it is important to recognise the increased rates of PTSD among LGBTQ+ individuals, understand the reasons behind this, and improve awareness of available treatment options.